Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.
The Mount Sinai Health System is seeking highly skilled molecular/cellneuroscientists and neuroimmunologists to contribute to translating Alzheimer's disease into effective treatments. The role focuses on studying human genetics in the context of AD, using various approaches like in vitro and in vivo studies. The team at the Ronald M. Loeb Center for Alzheimer’s Disease focuses on a range of research areas, including the role of microglia and the impact of genetics on brain health.
Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.